The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 1, Minde Road, Nanchang, 330006, Jiangxi, China.
Sci Rep. 2024 May 23;14(1):11825. doi: 10.1038/s41598-024-61818-5.
In the United States (US), chlamydia is the most frequently reported sexually transmitted infection that is nationally notifiable. We examined trends in chlamydia prevalence in the US in 2011-2016 compared with 2005-2010. Cross-sectional, nationally representative surveys, National Health and Nutrition Examination Surveys (NHANES), were used to compare national chlamydia prevalence estimates from 2011 to 2016 with those from 2005 to 2010, and changes in prevalence since 1999-2004 were also reviewed. Persons aged 18-39 years were included in these analyses. Prevalence of chlamydia was based on results from urine specimens. Results were weighted to represent the U.S. civilian, noninstitutionalized population. The baseline characteristics of the study population were similar in gender, age and race/ethnicity between the two groups (P > 0.05). The overall chlamydia prevalence was 1.88% (95% confidence interval [CI] 1.55-2.22%) in 2011-2016 and 1.57% (95% CI 1.27-1.87%) in 2005-2010, a relative increase of 19.7% (95% CI 0.2-39.2%; P < 0.05) between the two surveys. Increases in chlamydia prevalence was especially concentrated in persons who were male, aged 18 to 29 years, had > high school educational level, never married, age at first sex < 18 years, had 2-5 sexual partners in lifetime and had no past sexually transmitted diagnosis between 2005 and 2016 (P < 0.05). Multivariable logistic regression analysis demonstrated that chlamydia was more prevalent in those aged 18-29 years, being non-Hispanic Blacks, had high school educational level, being widowed/divorced/separated and had > 5 sexual partners. The chlamydia prevalence had an increasing trend from 2005-2010 to 2011-2016. Those with high chlamydia prevalence such as sexually active young adults and Non-Hispanic Black should be screened annually so that infected persons can be diagnosed and they and their sex partners can be treated promptly.
在美国,衣原体是报告发病率最高的性传播感染疾病,且需要全国通报。本研究旨在比较 2011-2016 年与 2005-2010 年美国衣原体流行率的变化趋势。采用全国代表性横断面调查——国家健康和营养调查(NHANES),比较 2011-2016 年和 2005-2010 年全国衣原体流行率估计值,并回顾自 1999-2004 年以来的流行率变化情况。本分析纳入年龄在 18-39 岁的人群。衣原体的流行率基于尿液标本的检测结果。结果经加权处理以代表美国的非住院平民人口。两组人群的基线特征(性别、年龄和种族/民族)相似(P>0.05)。2011-2016 年,总体衣原体流行率为 1.88%(95%置信区间 1.55%-2.22%),2005-2010 年为 1.57%(95%置信区间 1.27%-1.87%),两调查之间的相对增长率为 19.7%(95%置信区间 0.2%-39.2%;P<0.05)。衣原体流行率的上升尤其集中在男性、18-29 岁、高中学历、未婚、初次性行为年龄<18 岁、一生中发生 2-5 个性伴侣、2005-2016 年期间无既往性传播诊断的人群(P<0.05)。多变量逻辑回归分析表明,18-29 岁、非西班牙裔黑人、高中学历、丧偶/离婚/分居、性伴侣>5 个的人群中,衣原体更常见(P<0.05)。2005-2010 年至 2011-2016 年,衣原体流行率呈上升趋势。高流行率人群(如性活跃的年轻人和非西班牙裔黑人)应每年进行筛查,以便及时诊断感染者,并对其和性伴侣进行治疗。